202865-77-8 Usage
General Description
2-Bromo-4-Fluoro-6-Methyl Aniline is a specialized chemical compound. It has the molecular formula of C7H8BrFN and is commonly used in the pharmaceutical industry and also as a catalyst in various organic reactions. The chemical properties of this compound are largely determined by the presence of Bromo, Fluoro, Aniline groups and a Methyl group. These give the compound its unique chemical reactivity and characteristic properties. It is essential to handle this compound with care due to its reactive nature which can potentially initiate harmful reactions if not properly managed. Its specific binding to different chemical structures can be highly useful in the formation of new compounds in the laboratory setting.
Check Digit Verification of cas no
The CAS Registry Mumber 202865-77-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,2,8,6 and 5 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 202865-77:
(8*2)+(7*0)+(6*2)+(5*8)+(4*6)+(3*5)+(2*7)+(1*7)=128
128 % 10 = 8
So 202865-77-8 is a valid CAS Registry Number.
InChI:InChI=1/C7H7BrFN/c1-4-2-5(9)3-6(8)7(4)10/h2-3H,10H2,1H3
202865-77-8Relevant articles and documents
QUINOXALINE DERIVATIVES AS MODULATORS OF THE GLUCOCORTICOID RECEPTOR
-
Page/Page column 29-30, (2021/07/24)
The present invention relates to compounds according to general formula (I) which act as modulators of the glucocorticoid receptor and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by the glucocorticoid receptor.
4-CARBOXAMIDO-ISOINDOLINONE DERIVATIVES AS SELECTIVE PARP-1 INHIBITORS
-
Page/Page column 27, (2014/05/24)
There are provided substituted 4-carboxamido-isoindolinone derivatives which selectively inhibit the activity of poly (ADP-ribose) polymerase PARP-1 with respect to poly (ADP-ribose) polymerase PARP-2. The compounds of this invention are therefore useful in treating diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and methods of treating diseases utilizing pharmaceutical compositions comprising these compounds